tirzepatide and ulcerative colitis Updates in Medicine | 🔵 What's New in – 2025 ACG Guidelines 📎 Original article link in bio 👨‍⚕️ Learn the key updates in diagnosis & how do you say tirzepatide

The STEP 1 trial studied semaglutide 2.4 mg weekly in adults without diabetes and found 14.9% mean body weight loss versus 2.4% with placebo at 68 weeks

Identifying appropriate candidates requires evaluating multiple factors including current control, weight status, comorbidities, and treatment goals

[2] [1] If using tirzepatide alongside insulin or sulfonylureas, these doses may need reduction to prevent hypoglycaemia

and mapped reads were obtained using HTSeq

For further guidance on herbdrug interactions, the Specialist Pharmacy Service (SPS) provides UK-specific resources for healthcare professionals and patients

NPJ Prim Care Respir Med 2015;25:15005